Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
38.8M
-
Shares change
-
+862K
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$29.3M
-
Put/Call ratio
-
3.66
-
Number of buys
-
64
-
Number of sells
-
-51
-
Price
-
$27.03
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q2 2024
127 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q2 2024.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
.
Largest 10 shareholders include FMR LLC (4.42M shares), RA CAPITAL MANAGEMENT, L.P. (3.29M shares), FARALLON CAPITAL MANAGEMENT LLC (2.94M shares), Cormorant Asset Management, LP (2.79M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.51M shares), BlackRock Inc. (2.37M shares), VANGUARD GROUP INC (1.93M shares), WELLINGTON MANAGEMENT GROUP LLP (1.78M shares), VIKING GLOBAL INVESTORS LP (1.66M shares), and Polar Capital Holdings Plc (1.35M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.